Europe Pancreatic Cancer Diagnostic Market Size & Outlook
Europe pancreatic cancer diagnostic market, 2018-2030 (US$M)
Related Markets
Europe pancreatic cancer diagnostic market highlights
- The Europe pancreatic cancer diagnostic market generated a revenue of USD 808.0 million in 2023.
- The market is expected to grow at a CAGR of 4.1% from 2024 to 2030.
- In terms of segment, outpatient facilities was the largest revenue generating end use in 2023.
- Home Care is the most lucrative end use segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 808.0 million |
| Market revenue in 2030 | USD 1,069.8 million |
| Growth rate | 4.1% (CAGR from 2023 to 2030) |
| Largest segment | Outpatient facilities |
| Fastest growing segment | Home Care |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Hospitals, Outpatient Facilities, Home Care, Research & Manufacturing |
| Key market players worldwide | Thermo Fisher Scientific Inc, Qiagen NV, Illumina Inc, Roche Holding AG ADR, BD, Agilent Technologies Inc, Myriad Genetics Inc, Koninklijke Philips NV, Abbott Laboratories, Hitachi Ltd, Danaher Corp, Prestige Medical |
Other key industry trends
- In terms of revenue, Europe region accounted for 23.5% of the global pancreatic cancer diagnostic market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,089.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Pancreatic Cancer Diagnostic Market Scope
Pancreatic Cancer Diagnostic Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe pancreatic cancer diagnostic market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pancreatic cancer diagnostic market will help companies and investors design strategic landscapes.
Outpatient facilities was the largest segment with a revenue share of 63.89% in 2023. Horizon Databook has segmented the Europe pancreatic cancer diagnostic market based on hospitals, outpatient facilities, home care, research & manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
Europe accounts for a considerable revenue share of the pancreatic cancer diagnostics market due to the presence of developed economies, such as Germany, Spain, the UK, France, and Italy. These countries have advanced infrastructure, which is anticipated to significantly boost clinical research prospects in the region.
Moreover, the growing biotechnology industry and rising investments in genomic sequencing in countries, such as the UK & Germany, are some other major factors expected to improve market growth over the coming decade. In February 2022, Invitae introduced its Liquid Plex Dx and Fusion Plex Dx Cancer Testing Kit with the CE Mark for use in Europe.
The increasing prevalence and mortality rates of pancreatic cancer are significant drivers in the healthcare market. Higher incidence rates lead to greater demand for diagnostic technologies, including advanced imaging & biomarker tests, to improve early detection and treatment outcomes.
Reasons to subscribe to Europe pancreatic cancer diagnostic market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe pancreatic cancer diagnostic market databook
-
Our clientele includes a mix of pancreatic cancer diagnostic market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe pancreatic cancer diagnostic market , including forecasts for subscribers. This continent databook contains high-level insights into Europe pancreatic cancer diagnostic market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe pancreatic cancer diagnostic market size, by country, 2018-2030 (US$M)
Europe Pancreatic Cancer Diagnostic Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
